ADRENOMEDULLIN TO GUIDE THERAPY OF BLOOD PRESSURE DECLINE Russian patent published in 2018 - IPC G01N33/68 

Abstract RU 2673455 C2

FIELD: medicine.

SUBSTANCE: invention relates to medicine and can be used to identify in vitro a subject in need of fluid resuscitation or administration of a vasopressor, or to identify a patient at risk of developing physiological shock. Method comprises determining the level of proADM (SEQ ID No. 1) and / or fragments thereof, comprising at least 6 amino acids, in the body fluid of said subject. Level of proADM is compared with the need of said subject for fluid resuscitation or administration of a vasopressor. Patient is identified as a subject with such a need, if the level of proADM (SEQ ID No. 1) and / or fragments thereof in the body fluid of said subject exceeds the threshold value.

EFFECT: invention enables to identify a subject in need of fluid resuscitation or administration of a vasopressor.

19 cl, 7 dwg, 11 tbl, 8 ex

Similar patents RU2673455C2

Title Year Author Number
ADRENOMEDULLIN (ADM) FOR DIAGNOSTICS AND/OR PREDICTION OF DEMENTIA AND ANTIADRENOMEDULLIN-BINDING AGENT FOR USE IN THERAPY OR PREVENTION OF DEMENTIA 2019
  • Melander, Olle
RU2811309C2
THERAPY MONITORING IN TREATMENT WITH BINDING AGENT AGAINST ADRENOMEDULLIN (ADM) 2018
  • Struck, Joachim
  • Bergmann, Andreas
RU2776811C2
ANTIBODY TO ADRENOMEDULLIN (ADM) OR ANTI-ADM ANTIBODY ELEMENT, OR ANTI-ADM HE-IQ FRAMING FOR APPLICATION IN THERAPY 2012
  • Bergmann Andreas
RU2662671C2
ADRENOMEDULLIN ASSAY AND METHODS FOR DETERMINING MATURE ADRENOMEDULLIN 2012
  • Bergmann Andreas
RU2657517C2
MR-proADM AS MARKER FOR EXTRACELLULAR VOLUME STATUS OF SUBJECT 2016
  • Vigue, Bernard
  • Rafi-Nikoukhah, Homa
RU2778457C2
HISTONES AND/OR proADM AS MARKERS TESTIFYING ABOUT ORGAN DYSFUNCTION 2017
  • Tsira Tim
  • Drejer Frauke
  • Enkam Ann
  • Krop Manne
  • Sharl Per-Emmanyuel
RU2764766C2
ANTIBODY AGAINST ADRENOMEDULLIN (ADM), OR FRAGMENT OF ANTI-ADM ANTIBODY, OR ANTI-ADM NON-IG FRAME FOR USE IN INTERVENTION AND THERAPY OF HYPEREMIA IN PATIENT 2017
  • Voors, Adriaan
RU2762059C2
HISTONES AND/OR proADM AS MARKERS INDICATING ADVERSE EVENT 2017
  • Tsira Tim
  • Shenikhen Andre
  • Enkam Ann
  • Krop Manne
  • Kurdt Ingo
  • Sharl Per-Emmanyuel
RU2765212C2
PRO-ADM AS MONITORING MARKER OF THERAPY FOR CRITICALLY ILL PATIENTS 2018
  • Wilson Darius
RU2782305C2
COMPOUND BINDING ADRENOMEDULLIN (ADM) FOR USE FOR THERAPY OR PREVENTION OF DISEASE SYMPTOMS 2018
  • Bergmann, Andreas
RU2790561C2

RU 2 673 455 C2

Authors

Bergmann Andreas

Dates

2018-11-27Published

2014-03-19Filed